Adult Malignant Glioma Treatment - Global and China Top Players Market Share and Ranking 2023
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for Adult Malignant Glioma Treatment should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Adult Malignant Glioma Treatment market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Adult Malignant Glioma Treatment market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Glioblastoma Multiforme grew percent to account for percent of the total market sales, and Anaplastic Astrocytoma grew percent.
Malignant gliomas, tumors derived from the neuroepithelium are collectively referred to as gliomas (gliomas), accounting for 40-50% of brain tumors, and are the most common intracranial malignant tumors. According to pathology, it can be divided into astrocytoma, medulloblastoma, glioblastoma multiforme, ependymoma, oligodendroglioma and so on.
This report studies and analyses global Adult Malignant Glioma Treatment status and future trends, helps the client to determine the Adult Malignant Glioma Treatment market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Adult Malignant Glioma Treatment, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Adult Malignant Glioma Treatment market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Adult Malignant Glioma Treatment sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Adult Malignant Glioma Treatment sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Adult Malignant Glioma Treatment key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Adult Malignant Glioma Treatment key producing regions, capacity, production, and year over year growth
(6) Adult Malignant Glioma Treatment industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Merck & Co., Inc
F. Hoffmann-La Roche Ltd
Arbor Pharmaceuticals
Pfizer,Inc
AbbVie, Inc
Amgen, Inc
Bristol-Myers Squibb Company
Sun Pharmaceuticals Ltd
Teva Pharmaceutical Industries Limited
Emcure Pharmaceuticals Limited
Bayer
SL Pharm
Boan Biotech
Market segment by Type, covers
Chemotherapy
Targeted Drug Therapy
Market segment by Application, can be divided into
Glioblastoma Multiforme
Anaplastic Astrocytoma
Anaplastic Oligodendroglioma
Anaplastic Oligoastrocytoma
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Adult Malignant Glioma Treatment product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Adult Malignant Glioma Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Adult Malignant Glioma Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Adult Malignant Glioma Treatment, percent & CAGR, 2018-2029
Chapter 5: Adult Malignant Glioma Treatment industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Adult Malignant Glioma Treatment Definition
1.2 Global Adult Malignant Glioma Treatment Market Size and Forecast
1.2.1 By Consumption Value, Global Adult Malignant Glioma Treatment Market Size，2019-2030
1.2.2 By Sales Quantity, Global Adult Malignant Glioma Treatment Market Size，2019-2030
1.2.3 Global Adult Malignant Glioma Treatment Average Selling Price (ASP)，2019-2030
1.3 China Adult Malignant Glioma Treatment Market Size and Forecast
1.3.1 By Consumption Value, China Adult Malignant Glioma Treatment Market Size，2019-2030
1.3.2 By Sales Quantity, China Adult Malignant Glioma Treatment Market Size，2019-2030
1.3.3 China Adult Malignant Glioma Treatment Average Selling Price (ASP)， 2019-2030
1.4 Share of China Adult Malignant Glioma Treatment Market with Respect to the Global Market
1.4.1 By Consumption Value, China Adult Malignant Glioma Treatment Market Share in Global, 2019-2030
1.4.2 By Sales Quantity, China Adult Malignant Glioma Treatment Market Share in Global, 2019-2030
1.4.3 Adult Malignant Glioma Treatment Market Size: China VS Global, 2019-2030
1.5 Adult Malignant Glioma Treatment Market Dynamics
1.5.1 Adult Malignant Glioma Treatment Market Drivers
1.5.2 Adult Malignant Glioma Treatment Market Restraints
1.5.3 Adult Malignant Glioma Treatment Industry Trends
1.5.4 Adult Malignant Glioma Treatment Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Adult Malignant Glioma Treatment, Global Market Share by Company, 2019-2024
2.2 By Sales Quantity of Adult Malignant Glioma Treatment, Global Market Share by Company, 2019-2024
2.3 Adult Malignant Glioma Treatment Average Selling Price (ASP) by Company, 2019-2024
2.4 Global Adult Malignant Glioma Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Adult Malignant Glioma Treatment Concentration Ratio
2.6 Global Adult Malignant Glioma Treatment Mergers & Acquisitions, Expansion Plans
2.7 Global Adult Malignant Glioma Treatment Manufacturers Product Type
2.8 Head Office and Adult Malignant Glioma Treatment Production Site of Key Manufacturer
2.9 Adult Malignant Glioma Treatment Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Adult Malignant Glioma Treatment, China Market Share by Company, 2019-2024
3.2 By Sales Quantity of Adult Malignant Glioma Treatment, China Market Share by Company, 2019-2024
3.3 China Adult Malignant Glioma Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Adult Malignant Glioma Treatment Capacity, Output and Capacity Utilization, 2019-2030
4.2 Global Adult Malignant Glioma Treatment Capacity by Region
4.3 Global Adult Malignant Glioma Treatment Production & Forecast by Region, 2019 VS 2024 VS 2030
4.4 Global Adult Malignant Glioma Treatment Production by Region, 2019-2030
4.5 Global Adult Malignant Glioma Treatment Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Adult Malignant Glioma Treatment Industry Chain
5.2 Adult Malignant Glioma Treatment Upstream Analysis
5.2.1 Adult Malignant Glioma Treatment Core Raw Materials
5.2.2 Main Manufacturers of Adult Malignant Glioma Treatment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Adult Malignant Glioma Treatment Production Mode
5.6 Adult Malignant Glioma Treatment Procurement Model
5.7 Adult Malignant Glioma Treatment Industry Sales Model and Sales Channels
5.7.1 Adult Malignant Glioma Treatment Sales Model
5.7.2 Adult Malignant Glioma Treatment Typical Distributors
6 Sights by Type
6.1 Adult Malignant Glioma Treatment Classification
6.1.1 Chemotherapy
6.1.2 Targeted Drug Therapy
6.2 By Type, Global Adult Malignant Glioma Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Adult Malignant Glioma Treatment Consumption Value, 2019-2030
6.4 By Type, Global Adult Malignant Glioma Treatment Sales Quantity, 2019-2030
6.5 By Type, Global Adult Malignant Glioma Treatment Average Selling Price (ASP), 2019-2030
7 Sights by Application
7.1 Adult Malignant Glioma Treatment Segment by Application
7.1.1 Glioblastoma Multiforme
7.1.2 Anaplastic Astrocytoma
7.1.3 Anaplastic Oligodendroglioma
7.1.4 Anaplastic Oligoastrocytoma
7.1.5 Other
7.2 By Application, Global Adult Malignant Glioma Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Adult Malignant Glioma Treatment Consumption Value, 2019-2030
7.4 By Application, Global Adult Malignant Glioma Treatment Sales Quantity, 2019-2030
7.5 By Application, Global Adult Malignant Glioma Treatment Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Adult Malignant Glioma Treatment Consumption Value, 2019 VS 2024 VS 2030
8.2 By Region, Global Adult Malignant Glioma Treatment Consumption Value, 2019-2030
8.3 By Region, Global Adult Malignant Glioma Treatment Sales Quantity, 2019-2030
8.4 North America
8.4.1 North America Adult Malignant Glioma Treatment & Forecasts, 2019-2030
8.4.2 By Country, North America Adult Malignant Glioma Treatment Market Size Market Share
8.5 Europe
8.5.1 Europe Adult Malignant Glioma Treatment Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Adult Malignant Glioma Treatment Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Adult Malignant Glioma Treatment Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Adult Malignant Glioma Treatment Market Size Market Share
8.7 South America
8.7.1 South America Adult Malignant Glioma Treatment Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Adult Malignant Glioma Treatment Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Adult Malignant Glioma Treatment Market Size & CAGR, 2019 VS 2024 VS 2030
9.2 By Country, Global Adult Malignant Glioma Treatment Consumption Value, 2019-2030
9.3 By Country, Global Adult Malignant Glioma Treatment Sales Quantity, 2019-2030
9.4 U.S.
9.4.1 U.S. Adult Malignant Glioma Treatment Market Size, 2019-2030
9.4.2 By Type, U.S. Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Adult Malignant Glioma Treatment Market Size, 2019-2030
9.5.2 By Type, Europe Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Adult Malignant Glioma Treatment Market Size, 2019-2030
9.6.2 By Type, China Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Adult Malignant Glioma Treatment Market Size, 2019-2030
9.7.2 By Type, Japan Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Adult Malignant Glioma Treatment Market Size, 2019-2030
9.8.2 By Type, South Korea Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Adult Malignant Glioma Treatment Market Size, 2019-2030
9.9.2 By Type, Southeast Asia Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Adult Malignant Glioma Treatment Market Size, 2019-2030
9.10.2 By Type, India Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Adult Malignant Glioma Treatment Market Size, 2019-2030
9.11.2 By Type, Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Merck & Co., Inc
10.1.1 Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position
10.1.2 Merck & Co., Inc Adult Malignant Glioma Treatment Models, Specifications, and Application
10.1.3 Merck & Co., Inc Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Merck & Co., Inc Company Profile and Main Business
10.1.5 Merck & Co., Inc Recent Developments
10.2 F. Hoffmann-La Roche Ltd
10.2.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
10.2.2 F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Models, Specifications, and Application
10.2.3 F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.2.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business
10.2.5 F. Hoffmann-La Roche Ltd Recent Developments
10.3 Arbor Pharmaceuticals
10.3.1 Arbor Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.3.2 Arbor Pharmaceuticals Adult Malignant Glioma Treatment Models, Specifications, and Application
10.3.3 Arbor Pharmaceuticals Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Arbor Pharmaceuticals Company Profile and Main Business
10.3.5 Arbor Pharmaceuticals Recent Developments
10.4 Pfizer,Inc
10.4.1 Pfizer,Inc Company Information, Head Office, Market Area, and Industry Position
10.4.2 Pfizer,Inc Adult Malignant Glioma Treatment Models, Specifications, and Application
10.4.3 Pfizer,Inc Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Pfizer,Inc Company Profile and Main Business
10.4.5 Pfizer,Inc Recent Developments
10.5 AbbVie, Inc
10.5.1 AbbVie, Inc Company Information, Head Office, Market Area, and Industry Position
10.5.2 AbbVie, Inc Adult Malignant Glioma Treatment Models, Specifications, and Application
10.5.3 AbbVie, Inc Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.5.4 AbbVie, Inc Company Profile and Main Business
10.5.5 AbbVie, Inc Recent Developments
10.6 Amgen, Inc
10.6.1 Amgen, Inc Company Information, Head Office, Market Area, and Industry Position
10.6.2 Amgen, Inc Adult Malignant Glioma Treatment Models, Specifications, and Application
10.6.3 Amgen, Inc Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Amgen, Inc Company Profile and Main Business
10.6.5 Amgen, Inc Recent Developments
10.7 Bristol-Myers Squibb Company
10.7.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area, and Industry Position
10.7.2 Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Models, Specifications, and Application
10.7.3 Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Bristol-Myers Squibb Company Company Profile and Main Business
10.7.5 Bristol-Myers Squibb Company Recent Developments
10.8 Sun Pharmaceuticals Ltd
10.8.1 Sun Pharmaceuticals Ltd Company Information, Head Office, Market Area, and Industry Position
10.8.2 Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Models, Specifications, and Application
10.8.3 Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Sun Pharmaceuticals Ltd Company Profile and Main Business
10.8.5 Sun Pharmaceuticals Ltd Recent Developments
10.9 Teva Pharmaceutical Industries Limited
10.9.1 Teva Pharmaceutical Industries Limited Company Information, Head Office, Market Area, and Industry Position
10.9.2 Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Models, Specifications, and Application
10.9.3 Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Teva Pharmaceutical Industries Limited Company Profile and Main Business
10.9.5 Teva Pharmaceutical Industries Limited Recent Developments
10.10 Emcure Pharmaceuticals Limited
10.10.1 Emcure Pharmaceuticals Limited Company Information, Head Office, Market Area, and Industry Position
10.10.2 Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Models, Specifications, and Application
10.10.3 Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Emcure Pharmaceuticals Limited Company Profile and Main Business
10.10.5 Emcure Pharmaceuticals Limited Recent Developments
10.11 Bayer
10.11.1 Bayer Company Information, Head Office, Market Area, and Industry Position
10.11.2 Bayer Adult Malignant Glioma Treatment Models, Specifications, and Application
10.11.3 Bayer Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Bayer Company Profile and Main Business
10.11.5 Bayer Recent Developments
10.12 SL Pharm
10.12.1 SL Pharm Company Information, Head Office, Market Area, and Industry Position
10.12.2 SL Pharm Adult Malignant Glioma Treatment Models, Specifications, and Application
10.12.3 SL Pharm Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.12.4 SL Pharm Company Profile and Main Business
10.12.5 SL Pharm Recent Developments
10.13 Boan Biotech
10.13.1 Boan Biotech Company Information, Head Office, Market Area, and Industry Position
10.13.2 Boan Biotech Adult Malignant Glioma Treatment Models, Specifications, and Application
10.13.3 Boan Biotech Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Boan Biotech Company Profile and Main Business
10.13.5 Boan Biotech Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Adult Malignant Glioma Treatment Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Adult Malignant Glioma Treatment Market Restraints
Table 3. Adult Malignant Glioma Treatment Market Trends
Table 4. Adult Malignant Glioma Treatment Industry Policy
Table 5. Global Adult Malignant Glioma Treatment Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Adult Malignant Glioma Treatment Revenue Share by Company, 2019-2024, Ranked by Data of 2022
Table 7. Global Adult Malignant Glioma Treatment Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Adult Malignant Glioma Treatment Sales Quantity by Company, 2019-2024, Ranked by Data of 2022
Table 9. Global Adult Malignant Glioma Treatment Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)
Table 10. Global Adult Malignant Glioma Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Adult Malignant Glioma Treatment Mergers & Acquisitions, Expansion Plans
Table 12. Global Adult Malignant Glioma Treatment Manufacturers Product Type
Table 13. Head Office and Adult Malignant Glioma Treatment Production Site of Key Manufacturer
Table 14. Adult Malignant Glioma Treatment Capacity of Major Manufacturers and Future Plan
Table 15. China Adult Malignant Glioma Treatment Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022
Table 16. China Adult Malignant Glioma Treatment Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022
Table 17. China Adult Malignant Glioma Treatment Sales Quantity by Company, 2019-2024, Ranked by Data of 2022
Table 18. Global Adult Malignant Glioma Treatment Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 19. Global Adult Malignant Glioma Treatment Production by Region, 2019-2024, (K Units)
Table 20. Global Adult Malignant Glioma Treatment Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Adult Malignant Glioma Treatment Upstream (Raw Materials)
Table 22. Global Adult Malignant Glioma Treatment Typical Customers
Table 23. Adult Malignant Glioma Treatment Typical Distributors
Table 24. By Type, Global Adult Malignant Glioma Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 25. By Application, Global Adult Malignant Glioma Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 26. By Region, Global Adult Malignant Glioma Treatment Consumption Value, 2019 VS 2024 VS 2030, US$ Million
Table 27. By Region, Global Adult Malignant Glioma Treatment Consumption Value, 2019-2030, US$ Million
Table 28. By Region, Global Adult Malignant Glioma Treatment Sales Quantity, 2019-2030, (K Units)
Table 29. By Country, Global Adult Malignant Glioma Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Country, Global Adult Malignant Glioma Treatment Consumption Value, 2019-2030, US$ Million
Table 31. By Country, Global Adult Malignant Glioma Treatment Consumption Value Market Share, 2019-2030
Table 32. By Country, Global Adult Malignant Glioma Treatment Sales Quantity, 2019-2030, (K Units)
Table 33. By Country, Global Adult Malignant Glioma Treatment Sales Quantity Market Share, 2019-2030
Table 34. Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position
Table 35. Merck & Co., Inc Adult Malignant Glioma Treatment Models, Specifications, and Application
Table 36. Merck & Co., Inc Adult Malignant Glioma Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 37. Merck & Co., Inc Company Profile and Main Business
Table 38. Merck & Co., Inc Recent Developments
Table 39. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
Table 40. F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Models, Specifications, and Application
Table 41. F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 43. F. Hoffmann-La Roche Ltd Recent Developments
Table 44. Arbor Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 45. Arbor Pharmaceuticals Adult Malignant Glioma Treatment Models, Specifications, and Application
Table 46. Arbor Pharmaceuticals Adult Malignant Glioma Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Arbor Pharmaceuticals Company Profile and Main Business
Table 48. Arbor Pharmaceuticals Recent Developments
Table 49. Pfizer,Inc Company Information, Head Office, Market Area, and Industry Position
Table 50. Pfizer,Inc Adult Malignant Glioma Treatment Models, Specifications, and Application
Table 51. Pfizer,Inc Adult Malignant Glioma Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Pfizer,Inc Company Profile and Main Business
Table 53. Pfizer,Inc Recent Developments
Table 54. AbbVie, Inc Company Information, Head Office, Market Area, and Industry Position
Table 55. AbbVie, Inc Adult Malignant Glioma Treatment Models, Specifications, and Application
Table 56. AbbVie, Inc Adult Malignant Glioma Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. AbbVie, Inc Company Profile and Main Business
Table 58. AbbVie, Inc Recent Developments
Table 59. Amgen, Inc Company Information, Head Office, Market Area, and Industry Position
Table 60. Amgen, Inc Adult Malignant Glioma Treatment Models, Specifications, and Application
Table 61. Amgen, Inc Adult Malignant Glioma Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Amgen, Inc Company Profile and Main Business
Table 63. Amgen, Inc Recent Developments
Table 64. Bristol-Myers Squibb Company Company Information, Head Office, Market Area, and Industry Position
Table 65. Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Models, Specifications, and Application
Table 66. Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Bristol-Myers Squibb Company Company Profile and Main Business
Table 68. Bristol-Myers Squibb Company Recent Developments
Table 69. Sun Pharmaceuticals Ltd Company Information, Head Office, Market Area, and Industry Position
Table 70. Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Models, Specifications, and Application
Table 71. Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Sun Pharmaceuticals Ltd Company Profile and Main Business
Table 73. Sun Pharmaceuticals Ltd Recent Developments
Table 74. Teva Pharmaceutical Industries Limited Company Information, Head Office, Market Area, and Industry Position
Table 75. Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Models, Specifications, and Application
Table 76. Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Teva Pharmaceutical Industries Limited Company Profile and Main Business
Table 78. Teva Pharmaceutical Industries Limited Recent Developments
Table 79. Emcure Pharmaceuticals Limited Company Information, Head Office, Market Area, and Industry Position
Table 80. Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Models, Specifications, and Application
Table 81. Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. Emcure Pharmaceuticals Limited Company Profile and Main Business
Table 83. Emcure Pharmaceuticals Limited Recent Developments
Table 84. Bayer Company Information, Head Office, Market Area, and Industry Position
Table 85. Bayer Adult Malignant Glioma Treatment Models, Specifications, and Application
Table 86. Bayer Adult Malignant Glioma Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Bayer Company Profile and Main Business
Table 88. Bayer Recent Developments
Table 89. SL Pharm Company Information, Head Office, Market Area, and Industry Position
Table 90. SL Pharm Adult Malignant Glioma Treatment Models, Specifications, and Application
Table 91. SL Pharm Adult Malignant Glioma Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. SL Pharm Company Profile and Main Business
Table 93. SL Pharm Recent Developments
Table 94. Boan Biotech Company Information, Head Office, Market Area, and Industry Position
Table 95. Boan Biotech Adult Malignant Glioma Treatment Models, Specifications, and Application
Table 96. Boan Biotech Adult Malignant Glioma Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. Boan Biotech Company Profile and Main Business
Table 98. Boan Biotech Recent Developments
List of Figures
Figure 1. Adult Malignant Glioma Treatment Picture
Figure 2. Global Adult Malignant Glioma Treatment Consumption Value, (US$ million) & (2019-2030)
Figure 3. Global Adult Malignant Glioma Treatment Sales Quantity, (K Units) & (2019-2030)
Figure 4. Global Adult Malignant Glioma Treatment Average Selling Price (ASP), (2019-2030) & (US$/Unit)
Figure 5. China Adult Malignant Glioma Treatment Consumption Value, (US$ million) & (2019-2030)
Figure 6. China Adult Malignant Glioma Treatment Sales Quantity (K Units) & (2019-2030)
Figure 7. China Adult Malignant Glioma Treatment Average Selling Price (ASP), (US$/Unit) & (2019-2030)
Figure 8. By Consumption Value, China Adult Malignant Glioma Treatment Market Share of Global, 2019-2030
Figure 9. By Sales Quantity, China Adult Malignant Glioma Treatment Market Share of Global, 2019-2030
Figure 10. Global Adult Malignant Glioma Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Adult Malignant Glioma Treatment Key Participants, Market Share, 2022
Figure 12. Global Adult Malignant Glioma Treatment Capacity, Production and Capacity Utilization, 2019-2030
Figure 13. Global Adult Malignant Glioma Treatment Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Adult Malignant Glioma Treatment Production Market Share & Forecast by Region, 2019-2030
Figure 15. Adult Malignant Glioma Treatment Industry Chain
Figure 16. Adult Malignant Glioma Treatment Procurement Model
Figure 17. Adult Malignant Glioma Treatment Sales Model
Figure 18. Adult Malignant Glioma Treatment Sales Channels, Direct Sales, and Distribution
Figure 19. Chemotherapy
Figure 20. Targeted Drug Therapy
Figure 21. By Type, Global Adult Malignant Glioma Treatment Consumption Value, 2019-2030, US$ Million
Figure 22. By Type, Global Adult Malignant Glioma Treatment Consumption Value Market Share, 2019-2030
Figure 23. By Type, Global Adult Malignant Glioma Treatment Sales Quantity, 2019-2030, (K Units)
Figure 24. By Type, Global Adult Malignant Glioma Treatment Sales Quantity Market Share, 2019-2030
Figure 25. By Type, Global Adult Malignant Glioma Treatment Average Selling Price (ASP), 2019-2030, (US$/Unit)
Figure 26. Glioblastoma Multiforme
Figure 27. Anaplastic Astrocytoma
Figure 28. Anaplastic Oligodendroglioma
Figure 29. Anaplastic Oligoastrocytoma
Figure 30. Other
Figure 31. By Application, Global Adult Malignant Glioma Treatment Consumption Value, 2019-2030, US$ Million
Figure 32. By Application, Global Adult Malignant Glioma Treatment Consumption Value Market Share, 2019-2030
Figure 33. By Application, Global Adult Malignant Glioma Treatment Sales Quantity, 2019-2030, (K Units)
Figure 34. By Application, Global Adult Malignant Glioma Treatment Sales Quantity Market Share, 2019-2030
Figure 35. By Application, Global Adult Malignant Glioma Treatment Average Selling Price (ASP), 2019-2030, (US$/Unit)
Figure 36. By Region, Global Adult Malignant Glioma Treatment Consumption Value Market Share, 2019-2030
Figure 37. By Region, Global Adult Malignant Glioma Treatment Sales Quantity Market Share, 2019-2030
Figure 38. North America Adult Malignant Glioma Treatment Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 39. By Country, North America Adult Malignant Glioma Treatment Consumption Value Market Share, 2022
Figure 40. Europe Adult Malignant Glioma Treatment Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 41. By Country, Europe Adult Malignant Glioma Treatment Consumption Value Market Share, 2022
Figure 42. Asia Pacific Adult Malignant Glioma Treatment Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 43. By Country/Region, Asia Pacific Adult Malignant Glioma Treatment Consumption Value Market Share, 2022
Figure 44. South America Adult Malignant Glioma Treatment Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 45. By Country, South America Adult Malignant Glioma Treatment Consumption Value Market Share, 2022
Figure 46. Middle East & Africa Adult Malignant Glioma Treatment Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 47. U.S. Adult Malignant Glioma Treatment Sales Quantity, 2019-2030, (K Units)
Figure 48. By Type, U.S. Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe Adult Malignant Glioma Treatment Sales Quantity, 2019-2030, (K Units)
Figure 51. By Type, Europe Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 53. China Adult Malignant Glioma Treatment Sales Quantity, 2019-2030, (K Units)
Figure 54. By Type, China Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan Adult Malignant Glioma Treatment Sales Quantity, 2019-2030, (K Units)
Figure 57. By Type, Japan Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea Adult Malignant Glioma Treatment Sales Quantity, 2019-2030, (K Units)
Figure 60. By Type, South Korea Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia Adult Malignant Glioma Treatment Sales Quantity, 2019-2030, (K Units)
Figure 63. By Type, Southeast Asia Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 65. India Adult Malignant Glioma Treatment Sales Quantity, 2019-2030, (K Units)
Figure 66. By Type, India Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity, 2019-2030, (K Units)
Figure 69. By Type, Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches
Research Methodology:
Adult Malignant Glioma Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|